Gene · 28874
Papers2,209
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,209
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Meeting abstracts from the Annual Conference "Clinical Genetics of Cancer 2022". | Hered Cancer Clin Pract | 2023 | 37434214 | PubTator, text mining | PubMed |
| ALS Variants of Annexin A11's Proline-Rich Domain Impair Its S100A6-Mediated Fibril Dissolution. | ACS Chem Neurosci | 2023 | 37433222 | PubTator, text mining | PubMed |
| A novel peptide derived from vascular endothelial growth factor prevents amyloid beta aggregation and toxicity. | Aging Cell | 2023 | 37415305 | PubTator, text mining | PubMed |
| Board demographic characteristics, ownership structure, and multiple capitals disclosure: Evidence from heavily polluting firms. | Heliyon | 2023 | 37389041 | PubTator, text mining | PubMed |
| Prediction of Temperature-Dependent Mechanical Properties for SWCNT/Cu Nanocomposite Metamaterials: A Molecular Dynamics Study. | Nanomaterials (Basel) | 2023 | 37368315 | PubTator, text mining | PubMed |
| Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens. | Cancer Immunol Immunother | 2023 | 37368077 | PubTator, text mining | PubMed |
| Induced alpha and beta electroencephalographic rhythms covary with single-trial speech intelligibility in competition. | Sci Rep | 2023 | 37353552 | PubTator, text mining | PubMed |
| Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates. | Front Microbiol | 2023 | 37350788 | PubTator, text mining | PubMed |
| Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement. | Front Immunol | 2023 | 37334355 | PubTator, text mining | PubMed |
Parahiraciini planthoppers with elongate head from Vietnam: a new genus and species Pumatiraciavenosa gen. et sp. nov. and first record of Laohiraciaacuta Constant, 2021 (Hemiptera, Fulgoromorpha, Issidae). | Zookeys | 2023 | 37333900 | PubTator, text mining | PubMed |
| A recombinant technique for mapping functional sites of heterotrimeric collagen helices: Collagen IV CB3 fragment as a prototype for integrin binding. | J Biol Chem | 2023 | 37302550 | PubTator, text mining | PubMed |
| α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies. | Neural Regen Res | 2023 | 37282450 | PubTator, text mining | PubMed |
| Heterogeneous expression of alternatively spliced lncRNA mediates vascular smooth cell plasticity. | Proc Natl Acad Sci U S A | 2023 | 37276403 | PubTator, text mining | PubMed |
| Molecular structure of soluble vimentin tetramers. | Sci Rep | 2023 | 37258554 | PubTator, text mining | PubMed |
| [Identification and verification of α-11 giardin-interacting protein]. | Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi | 2023 | 37253564 | PubTator, text mining | PubMed |
| Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines. | Pharmaceutics | 2023 | 37242727 | PubTator, text mining | PubMed |
| Characterization of RBD-specific cross-neutralizing antibodies responses against SARS-CoV-2 variants from COVID-19 convalescents. | Front Immunol | 2023 | 37234155 | PubTator, text mining | PubMed |
| The E2 ubiquitin-conjugating enzymes UBE2D1 and UBE2D2 regulate VEGFR2 dynamics and endothelial function. | J Cell Sci | 2023 | 37226882 | PubTator, text mining | PubMed |
| Algorithm selection for protein-ligand docking: strategies and analysis on ACE. | Sci Rep | 2023 | 37217655 | PubTator, text mining | PubMed |
| Dynamic accumulation of cyclobutane pyrimidine dimers and its response to changes in DNA conformation. | Nucleic Acids Res | 2023 | 37207339 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28874/papers?page=6